Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587504 · ClinicalTrials.gov registry record · NA
Determination of Liquid Flavor and Nicotine Form Outcomes
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05587504 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 13 participants.
The verdict
NCT05587504, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out how different types of electronic cigarette/vape e-liquids with differing sweetness and forms of nicotine affect blood nicotine levels, use behavior (how people puff), and how people feel.
Interventions
- OTHER E-cigarette with sweetness type 1 and pronation level 1
- OTHER E-cigarette with sweetness type 1 and pronation level 2
- OTHER E-cigarette with sweetness type 2 and pronation level 1
- OTHER E-cigarette with sweetness type 2 and pronation level 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-07-21 |
| Est. Completion | 2024-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05587504
The ClinicalTrials.gov registry entry for NCT05587504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which E-cigarette with sweetness type 1 and pronation level 1 is the first listed.
NCT05587504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05587504 about?
NCT05587504 is a clinical study titled "Determination of Liquid Flavor and Nicotine Form Outcomes". The purpose of this research study is to find out how different types of electronic cigarette/vape e-liquids with differing sweetness and forms of nicotine affect blood nicotine levels, use behavior (how people puff), and how people feel.
What is the current status of trial NCT05587504?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2023-07-21. Estimated completion is 2024-07-24.
What interventions are being tested in trial NCT05587504?
The interventions under investigation include: E-cigarette with sweetness type 1 and pronation level 1 (OTHER), E-cigarette with sweetness type 1 and pronation level 2 (OTHER), E-cigarette with sweetness type 2 and pronation level 1 (OTHER), E-cigarette with sweetness type 2 and pronation level 2 (OTHER).
Who is sponsoring clinical trial NCT05587504?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.